A retrospective multicenter study evaluating the efficacy and safety of irinotecan in patients with advanced gastric cancer: Analysis of albumin-bilirubin (ALBI) grade.

Iori Motoo,Yoshito Komatsu,Satoshi Yuki,Shintaro Nakano,Hiroshi Nakatsumi,Yasuyuki Kawamoto,Tetsuhito Muranaka,Kentaro Sawada,Takayuki Ando,Takuto Miyagishima,Kazuaki Harada,Yoshimitsu Kobayashi,Kazuteru Hatanaka,Atsushi Ishiguro,A. Tanimoto,Takuya Honda,Masayoshi Dazai,Takahide Sasaki,Naoya Sakamoto

A retrospective multicenter study evaluating the efficacy and safety of irinotecan in patients with advanced gastric cancer: Analysis of albumin-bilirubin (ALBI) grade.

2020

Iori Motoo
Yoshito Komatsu
Satoshi Yuki
Shintaro Nakano
Hiroshi Nakatsumi
Yasuyuki Kawamoto
Tetsuhito Muranaka
Kentaro Sawada
Takayuki Ando
Takuto Miyagishima
Kazuaki Harada
Yoshimitsu Kobayashi
Kazuteru Hatanaka
Atsushi Ishiguro
A. Tanimoto
Takuya Honda
Masayoshi Dazai
Takahide Sasaki
Naoya Sakamoto

415Background: It is important to predict prognosis and risk of adverse events in patients with advanced gastric cancer receiving chemotherapy. Albumin-bilirubin (ALBI) grade is recently used as li...

Keywords:

Irinotecan
Gastroenterology
Cancer
Albumin
Bilirubin
Internal medicine
multicenter study
Medicine
Pathology
in patient
advanced gastric cancer
Adverse effect
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations